pharmaceutical composition containing a combination of u043du0438u043au043eu0442u0438u043du0430u043cu0438u0434u0430 and 5 - u0430u043cu0438u043du043eu0441u0430u043bu0438u0446u0438u043bu043eu0432u043eu0439 acid, to provide a useful influence on the intestinal microbiota and / or u043bu0435u0447u0435u043du0438 i'm the inflammation in the gastro intestinal tract

摘要

The present invention relates to a new pharmaceutical composition containing a combination of 5-aminosalicylic acid and nicotinamide or related compounds. The combination is believed to beneficially influence the intestinal microbiota and/or reduce gastrointestinal inflammation. In certain embodiments, the pharmaceutical composition is partially or entirely released into the small intestine or large intestine.